Australia - engelsk - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 16800 - chart, eye, visual acuity - a chart displaying letters or symbols, in gradually decreasing sizes, used in the testing of visual acuity.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

boc ophthalmic instruments pty ltd - 35922 - projector, eye, visual acuity - this device projects images of letters and symbols onto a screen and is used to check the visual acuity of a patient by an optometrist

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

optimed pty ltd - 35922 - projector, eye, visual acuity - an ophthalmic device, a kind of slide projector/beamer throwing block letters or other symbols on a screen/wall in gradually decreasing sizes, identified according to distances at which they are ordinarily visible; used in testing visual acuity.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

astrazeneca limited - ticagrelor 90mg;  ;  ;   - film coated tablet - 90 mg - active: ticagrelor 90mg       excipient: calcium hydrogen phosphate hyprolose hypromellose iron oxide yellow macrogol 400 magnesium stearate mannitol purified talc purified water   sodium starch glycolate titanium dioxide - brilinta, co-administered with acetylsalicylic acid (aspirin), is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) · in patients with acute coronary syndromes (unstable angina [ua], non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]); including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg). · in patients with a history of myocardial infarction (mi occurred at least one year ago) and a high risk of developing an atherothrombotic event.

Israel - engelsk - Ministry of Health

isorad ltd, israel - medronic acid - solution for injection - medronic acid 10 mg/vial - technetium (99mtc) medronic acid - technetium (99mtc) medronic acid - bone imaging.

Singapore - engelsk - HSA (Health Sciences Authority)

bausch & lomb (singapore) private limited - acetylcholine chloride - injection - 20 mg/2 ml - acetylcholine chloride 20 mg/2 ml

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

astrazeneca limited - ticagrelor 60mg;  ;  ;   - film coated tablet - 60 mg - active: ticagrelor 60mg       excipient: calcium hydrogen phosphate hyprolose hypromellose iron oxide black iron oxide red macrogol 400 magnesium stearate mannitol purified water   sodium starch glycolate titanium dioxide - brilinta, co-administered with acetylsalicylic acid (aspirin), is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) · in patients with acute coronary syndromes (unstable angina [ua], non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]); including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg). · in patients with a history of myocardial infarction (mi occurred at least one year ago) and a high risk of developing an atherothrombotic event.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; hypromellose; macrogol 400 - metformin is indicated in the treatment of type 2 diabetes mellitus not satisfactorily controlled by diet, where the risk of lactic acidosis is minimised by excluding predisposing factors, especially impaired renal, hepatic or cardiovascular function. metformin may be used as initial therapy or in sulfonylurea failure, either alone or in combination with a sulfonylurea or as adjuvant therapy in insulin-dependent diabetes.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; hypromellose; macrogol 400 - metformin is indicated in the treatment of type 2 diabetes mellitus not satisfactorily controlled by diet, where the risk of lactic acidosis is minimised by excluding predisposing factors, especially impaired renal, hepatic or cardiovascular function. metformin may be used as initial therapy or in sulfonylurea failure, either alone or in combination with a sulfonylurea or as adjuvant therapy in insulin-dependent diabetes.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

optimed pty ltd - 16800 - chart, eye, visual acuity - an ophthalmic chart imprinted with block letters or other symbols in gradually decreasing sizes, identified according to distances at which they are ordinarily visible; used in testing visual acuity.